Iterum Therapeutics plc (NASDAQ:ITRM) Sees Significant Decre

Iterum Therapeutics plc (NASDAQ:ITRM – Get Rating) was the target of a significant decrease in short interest during the month of March. As of March 15th, there was short interest totalling 154,400 shares, a decrease of 15.5% from the February 28th total of 182,700 shares. Based on an average daily volume of 101,600 shares, the […]

Related Keywords

Dublin , Ireland , Coreyn Fishman , , Nasdaq , Iterum Therapeutics Plc , Goldman Sachs Group Inc , Dimensional Fund Advisors , Renaissance Technologies , Iterum Therapeutics Company Profile , Iterum Therapeutics , Get Rating , Sachs Group , Therapeutics Plc , Iterum Therapeutics Daily , Nasdaq Itrm , Itrm , Medical , Stocks , Options , Put , Call ,